格隆匯公吿精選(港股)︱中信證券(06030.HK):華夏基金2024年淨利潤21.58億元
【今日焦點】
中信證券(06030.HK):華夏基金2024年淨利潤21.58億元
中信證券(06030.HK)公吿,截至2024年12月31日,華夏基金總資產人民幣202.34億元,總負債人民幣63.02億元;2024年實現營業收入人民幣80.31億元,淨利潤人民幣21.58億元,綜合收益總額人民幣21.81億元。截至2024年12月31日,華夏基金母公司管理資產規模為人民幣24,645.31億元。
【財報業績】
希瑪醫療(03309.HK)預期2024財政年度收益約19.00億港元
中國罕王(03788.HK)預期2024年溢利約1.75億元,同比增加約16%
【運營數據】
弘陽地產(01996.HK):1月份合約銷售金額6.69億元
信利國際(00732.HK):1月綜合營業淨額10.5億港元 同比減少35.9%
【醫藥創新】
復星醫藥(02196.HK):復宏漢霖自主研發的斯魯利單抗注射液聯合卡鉑和依託泊苷適用於廣泛期小細胞肺癌(ES-SCLC)成人患者的一線治療的上市許可申請獲歐盟批准
君實生物(01877.HK):JS213獲得藥物臨牀試驗批准通知書
【回購註銷】
友邦保險(01299.HK)2月5日耗資3.61億港元回購676萬股
匯豐控股(00005.HK)2月4日耗資1.76億港元回購219.76萬股
保誠(02378.HK)2月4日耗資930萬英鎊回購139.2萬股
遼港股份(02880.HK)累計回購約2.4億股A股
泰格醫藥(03347.HK)2月5日耗資4633.43萬元回購93.77萬股A股
時代電氣(03898.HK)2月5日耗資2800.08萬港元回購95.93萬股
中石化油服(01033.HK):截至1月31日回購A股股份406.61萬股
中遠海控(01919.HK)2月5日耗資2797萬港元回購240萬股
太古股份公司A(00019.HK)2月5日耗資1652萬港元回購25萬股
波司登(03998.HK)2月5日耗資1120.75萬港元回購300萬股
鍋圈(02517.HK)2月5日耗資1000萬港元回購522.4萬股
麗珠醫藥(01513.HK)2月5日耗資999.67萬元回購27.4萬股A股
石四藥集團(02005.HK)2月5日註銷404.6萬股
渣打集團(02888.HK)2月4日註銷53.84萬股購回股份
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.